Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence

Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence

Novel fully automated multiomics assay for profiling the immune cell landscape and activation states

Novel fully automated multiomics assay for profiling the immune cell landscape and activation states

Morpho-molecular features of Epithelial Mesenchymal Transition associate with clinical outcome in patients with rectal cancer

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Understanding the Role of the Immune Contexture in Invasion and Metastasis of Solid Tumors Using Multiplexed Immunofluorescence and Image Analysis

Spatial predictors of response to immunotherapy inmicrosatellite stable metastatic colorectal cancer

NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy

Progressive plasticity during colorectal cancer metastasis

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1

Evaluation of IDH-1, EGF-R, IGF-1R and Ki-67 biomarkers in glioblastoma using the Lunaphore COMET™ platform

Evaluation of IDH-1, EGF-R, IGF-1R and Ki-67 biomarkers in glioblastoma using the Lunaphore COMET™ platform

Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma